Outro Secures $7M to Build Healthcare’s First Neuroscience-Based Deprescribing Platform13. Oktober 2026
News Ascensia leads $36M funding round for glucose sensor startupHealthradar12. Oktober 2026 Dive Brief: Ascensia Diabetes Care led a $36 million Series B round in London-based glucose sensor maker Sava Technologies, the…
News Senseonics to Take Over Eversense 365 Commercialization from AscensiaHealthradar4. September 2025 What You Should Know: – Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has…
